QPP, quiescent cell proline dipeptidase
Conventional anti-obesity medications are limited to short-term use and have adverse effects, which have contributed to the rise of GLP-1 RAs, e.g., liraglutide, semaglutide, dulaglutide
In online forums and informal use, Melanotan often defaults to Melanotan II because it is cheaper to produce, more potent at tanning, and widely available, albeit without any formal assurances on purity or dose accuracy
Cravings may return
Insufficient protein intake can lead to risks such as bone mass loss, reduced metabolic activity, and increased gastrointestinal side effects
Pharma manufacturers can make up for not being first by committing to innovative drug development that drives more efficacious products, pursuing new clinical indications, and correctly anticipating market developments that may impact supply and demand